These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10811688)

  • 1. Dopamine agonists: their role in the treatment of Parkinson's disease.
    Brooks DJ
    J Neurol Neurosurg Psychiatry; 2000 Jun; 68(6):685-9. PubMed ID: 10811688
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine agonists and Parkinson's disease progression: what can we learn from neuroimaging studies.
    Marek K; Jennings D; Seibyl J
    Ann Neurol; 2003; 53 Suppl 3():S160-6; discussion S166-9. PubMed ID: 12666107
    [No Abstract]   [Full Text] [Related]  

  • 3. The dark side of dopaminergic therapies in Parkinson's disease: shedding light on aberrant salience.
    Poletti M
    CNS Spectr; 2018 Dec; 23(6):347-351. PubMed ID: 28264738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous dopaminergic stimulation: is it the answer to the motor complications of levodopa?
    Zappia M; Quattrone A
    Mov Disord; 2008 May; 23(7):1062-1063. PubMed ID: 17994584
    [No Abstract]   [Full Text] [Related]  

  • 5. [Medicinal treatment of idiopathic Parkinson's disease].
    Klockgether T
    Nervenarzt; 2003 Mar; 74 Suppl 1():S12-21. PubMed ID: 12624679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New medication recommended for Parkinson's disease.
    Levenson D
    Rep Med Guidel Outcomes Res; 2001 Jun; 12(13):7-9. PubMed ID: 12182172
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopamine receptor agonists and sleep disturbances in Parkinson's disease.
    Chaudhuri KR; Logishetty K
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S101-4. PubMed ID: 20123546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical treatment of Parkinson disease.
    Stacy M
    Neurol Clin; 2009 Aug; 27(3):605-31, v. PubMed ID: 19555824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surgical treatment of Parkinson's disease as a supplement to pharmacological therapy].
    Jabłońska B; Dabek J; Lepich T
    Wiad Lek; 2006; 59(11-12):823-8. PubMed ID: 17427499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of adverse events linked to dopamine agonists in the treatment of Parkinson's disease.
    Ceravolo R; Rossi C; Del Prete E; Bonuccelli U
    Expert Opin Drug Saf; 2016; 15(2):181-98. PubMed ID: 26646536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DA agonists -- non-ergot derivatives: piribedil: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S90-2. PubMed ID: 12211147
    [No Abstract]   [Full Text] [Related]  

  • 12. Pergolide monotherapy for Parkinson's disease.
    van der Worp B
    J Neurol; 1999 Oct; 246(10):983-4. PubMed ID: 10610397
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopamine agonist switching in Parkinson's disease.
    Stewart D; Morgan E; Burn D; Grosset D; Chaudhuri KR; MacMahon D; Needleman F; Macphee G; Heywood P
    Hosp Med; 2004 Apr; 65(4):215-9. PubMed ID: 15127675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine receptor agonists in the therapy of Parkinson's disease.
    Foley P; Gerlach M; Double KL; Riederer P
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1375-446. PubMed ID: 15480844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Not Available].
    Grabli D
    Presse Med; 2017 Mar; 46(2 Pt 1):187-194. PubMed ID: 28233705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dopamine receptor agonists: new forms and new possibilities in the treatment of Parkinson's disease].
    Katunina EA; Titova NV; Bezdolny YN; Shykkerimov RK; Gasanov MG; Burd SG; Lebedeva AV; Boiko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(5):34-40. PubMed ID: 26356158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DA agonists -- non-ergot derivatives: apomorphine: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S83-9. PubMed ID: 12211146
    [No Abstract]   [Full Text] [Related]  

  • 18. DA agonists -- ergot derivatives: pergolide: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S79-82. PubMed ID: 12211145
    [No Abstract]   [Full Text] [Related]  

  • 19. Fibrosis associated with dopamine agonist therapy in Parkinson's disease.
    Müller T; Fritze J
    Clin Neuropharmacol; 2003; 26(3):109-11. PubMed ID: 12782910
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drug therapy in Parkinson's disease].
    Jansen EN
    Ned Tijdschr Geneeskd; 1999 Apr; 143(15):817. PubMed ID: 10347646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.